Ratchaphruek Hospital Public (RPH.BK) Earnings Analysis
Ratchaphruek Hospital Public (RPH.BK) next reports earnings on 2026-08-10, consensus EPS 0.03 THB. Last quarter (2025-12-30) it beat with EPS 0.08106 THB vs 0.03 THB est (+170.2%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 15.82.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RPH.BK next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | 0.03 THB |
| Revenue estimate | 0.20B |
RPH.BK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-12-30 | 0.08106 THB | 0.03 THB | +170.2% | Beat |
| 2025-11-10 | 0.112 THB | n/a | n/a | n/a |
| 2025-06-30 | 0.0684 THB | n/a | n/a | n/a |
| 2025-05-12 | 0.08063 THB | n/a | n/a | n/a |
| 2025-02-16 | 0.07 THB | n/a | n/a | n/a |
| 2024-11-11 | 0.12 THB | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
RPH.BK valuation and analyst view
| Trailing P/E | 15.82 |
|---|---|
| Trailing EPS | 0.3171 THB |
| Price / book | 1.51 |
| Dividend yield | 5.62% |
| Market cap | 2.64B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ratchaphruek Hospital Public (RPH.BK)'s next earnings date?
Ratchaphruek Hospital Public is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 0.03 THB and revenue estimate of 0.20B.
Did RPH.BK beat earnings last quarter?
In its 2025-12-30 report, RPH.BK posted EPS of 0.08106 THB versus a 0.03 THB estimate — a beat of 170.2%.
What is RPH.BK's earnings track record?
Over the last 1 reported quarters with consensus data, RPH.BK beat estimates 1 times (100%).
What is RPH.BK's current P/E ratio and EPS?
RPH.BK trades at a trailing P/E of 15.82 on trailing EPS of 0.3170972921881809 THB.
What do analysts rate RPH.BK?
RPH.BK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.